The Patent Finder

Cytodyn, Inc.

Also on record
Records under this name other than the patents Cytodyn, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Cytodyn, Inc.

PatentTitleStatus Expires Confidence
US 8,821,877Methods for Inhibiting HIV-1 Replication Involving the Administration of an ANTI-CCR5 Receptor Monoclonal Antibody and Small Molecule CCR5 Receptor Antagonist.
Term ended
Term ended Jul 21, 2026 · High confidence
Term endedTerm ended Jul 21, 2026High confidence
US 11,045,546Methods of treating coronavirus infection
Formerly held
Lapsed on the fee record
Ended Jun 29, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 29, 2025From the USPTO record
US 7,122,185ANTI-CCR5 Antibody
Formerly held
Term ended
Term ended Jun 1, 2024 · High confidence
Term endedTerm ended Jun 1, 2024High confidence
US 10,562,969Substitution monotherapy treatment for HIV-1 infection employing antibody PRO140
Lapsed on the fee record
Ended Feb 18, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 18, 2024From the USPTO record
US 10,500,274Methods for reducing viral load in HIV-1 infected patients
Lapsed on the fee record
Ended Dec 10, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 10, 2023From the USPTO record
US 7,666,419ANTI-CCR5 Antibody
Formerly held
Term ended
Term ended Feb 21, 2023 · High confidence
Term endedTerm ended Feb 21, 2023High confidence
US 7,851,600ANTI-CCR5 Antibody
Formerly held
Lapsed on the fee record
Ended Dec 14, 2022 · High confidence
Lapsed on the fee recordEnded Dec 14, 2022High confidence
US 7,060,273Methods for Inhibiting HIV-1 Infection
Term ended
Ended no later than Nov 19, 2022 · Medium confidence
Term endedEnded no later than Nov 19, 2022Medium confidence
US 7,138,119Compositions and Methods for Inhibition of HIV-1 Infection
Term ended
Term ended Nov 1, 2022 · Medium confidence
Term endedTerm ended Nov 1, 2022Medium confidence
US 9,499,621Felinized antibodies and methods of treating retroviral infections in felines
Lapsed on the fee record
Ended Nov 22, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 22, 2020From the USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited